Adenocarcinoma

Adenocarcinoma is a cancer that originates in glandular tissue. To be classified as adenocarcinoma, the cells do not necessarily need to be part of a gland, as long as they have secretory properties. This form of carcinoma can occur in some higher mammals, including humans.The term adenocarcinoma is derived from 'adeno' meaning 'pertaining to a gland' and 'carcinoma', which describes a cancer that has developed in the epithelial cells. It can first present as an adenoma . (From the Wikpedia article Adenocarcinoma.)

Download PDF containing detailed information.

Recent Publications on Adenocarcinoma:
Claudins in human cancer: A review. Claudins are tight junction proteins that are critical for the sealing of...	20th November, 2009	Departments of Pathology, Saba University School of Medicine, Saba,	Histol Histopathol. 2010 Jan;25(1):83-90.
Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines. In defining the genetic profiles in cancer, cytogenetically aberrant cell...	31st May, 2008	Section of Cancer Genomics, Genetics Branch, Center for Cancer Research,	Genes Chromosomes Cancer. 2009 Nov 19. DOI Direct Link
Cervical cytology in patients with postmenopausal bleeding. In this study, the role of cervical cytology in the diagnosis of post or...	31st May, 2008	Department of Cytology, Post Graduate Institute of Medical Education and	Diagn Cytopathol. 2009 Nov 19. DOI Direct Link
Platypnea-Orthodeoxia, An Uncommon Presentation of Patent Foramen Ovale. The platypnea-orthodeoxia syndrome is a rare clinical presentation. The...	31st May, 2008	From the Departments of Medicine (aan, ln, gmb) and Pathology (ln),	Am J Med Sci. 2009 Nov 18. DOI Direct Link
[Hormone refractory prostate carcinoma metastasizes to the penis: a case report.] A 76-year-oldman presentedwith urinary retention andpenile discomfort. At...	31st May, 2008	The Department of Urology, Kansai Electric Power Hospital.	Hinyokika Kiyo. 2009 Oct;55(10):627-629.
→View more research publications.

Press Releases About Adenocarcinoma:
Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents	6th October, 2009	Boston Scientific Corporation	NATICK, Mass., Oct. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to
Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference	19th June, 2009	Helix BioPharma Corp.	AURORA, Ontario, June 19 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: HBP) today announced that Dr. Heman Chao, chief scientific officer at Helix BioPharma Corp., will be presenting a
NCCN Announces Updates to Pancreatic Adenocarcinoma Guidelines	13th March, 2009	National Comprehensive Cancer Network	New updates to the NCCN Guidelines for Pancreatic Adenocarcinoma were announced on March 12 at the NCCN 14th Annual Conference. Notable additions include updates on when a laparoscopy may be
Boston Scientific Introduces the 'Platinum Standard'(1) in Biliary Metal Stenting with the International Launch of WallFlex(R) Biliary RX Stenting System	16th October, 2008		NATICK, Massachusetts and PARIS, October 16 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the European availability of the WallFlex(R) Biliary RX Stent for the palliative
BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial	17th July, 2008	BioNumerik Pharmaceuticals, Inc.	SAN ANTONIO, July 17 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced that patients with adenocarcinoma (the most frequently occurring form of lung cancer)

BioNews Results for Adenocarcinoma:
Dendreon Corporation (DNDN) (JOBS) Receives FDA Acknowledgement of Complete Response, PDUFA Date Assigned as M	BioSpace:  Nov 21 2009 12:40AM Matching: adenocarcinoma
Dendreon Gets FDA Acceptance For Prostrate Cancer Drug Application - Update	RTTNews.com:  Nov 20 2009 4:58PM Matching: adenocarcinoma
Dendreon Receives FDA Acknowledgement of Complete Response	KSLA:  Nov 20 2009 4:38PM Matching: adenocarcinoma
FDA acknowledges Dendreon's amended BLA for PROVENGE as a complete response	News-Medical.Net:  Nov 20 2009 2:34PM Matching: adenocarcinoma
Dendreon Receives FDA Acknowledgement of Complete Response	Genetic Engineering News:  Nov 20 2009 2:13PM Matching: adenocarcinoma
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Adenocarcinoma Clinical Trials:
Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas

Adenocarcinoma Patents:
US Patent No.	Title
7612052	Combinations comprising epothilones and pharmaceutical uses thereof
7615214	Anti-human VEGF receptor Flt-1 monoclonal antibody
7615215	Anti-human VEGF receptor Flt-1 monoclonal antibody
7615217	Artificial proteins with reduced immunogenicity
7615219	Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Adenocarcinoma scientists - we have details of around 12623 individuals working on Adenocarcinoma .